InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
wiltonio Free
09/30/17 2:22 AM
profile icon
wiltonio Free
09/28/17 2:31 PM
profile icon
OTCWealth101 Free
09/21/17 10:10 PM
profile icon
Toninho Free
09/21/17 9:43 AM
profile icon
VERITAS77 Free
09/18/17 11:33 AM
profile icon
deadjim Free
09/16/17 1:01 PM
profile icon
Awl416 Free
08/22/17 5:05 PM
profile icon
OTCWealth101 Free
08/16/17 4:41 AM
profile icon
Coz Mabluda Free
08/05/17 3:18 AM
profile icon
BESTTIPSMONEY Terminated
07/14/17 10:34 AM
profile icon
BESTTIPSMONEY Terminated
07/13/17 11:04 AM
profile icon
Lone Wolf Free
07/13/17 9:02 AM
profile icon
ClayTrader Free
07/11/17 5:05 PM
profile icon
Lone Wolf Free
07/11/17 11:27 AM
profile icon
#NeverPennyLand Free
07/11/17 10:46 AM
profile icon
shurtha2000 Free
07/08/17 12:01 PM
profile icon
shurtha2000 Free
07/07/17 9:52 AM
profile icon
nanergy Terminated
07/06/17 3:46 PM
profile icon
nanergy Terminated
07/06/17 3:45 PM
profile icon
ClayTrader Free
07/03/17 2:21 PM
profile icon
G3TCRUNK3R Free
07/03/17 1:31 PM
profile icon
james_west_1965 Free
07/03/17 12:42 PM
profile icon
snakess Free
07/03/17 9:46 AM
profile icon
UP Trend Free
07/03/17 9:43 AM
profile icon
Tdash Free
07/03/17 9:37 AM
profile icon
shurtha2000 Free
07/03/17 9:36 AM
profile icon
shurtha2000 Free
07/03/17 9:32 AM
profile icon
shurtha2000 Free
07/03/17 9:17 AM
profile icon
Lone Wolf Free
05/23/17 7:41 PM
profile icon
shurtha2000 Free
05/23/17 9:42 AM
profile icon
whatsitworth Free
03/02/17 3:28 AM
profile icon
LV_Trader Free
02/23/17 11:23 PM
profile icon
whatsitworth Free
02/19/17 2:37 PM
profile icon
LV_Trader Free
02/15/17 12:00 PM
profile icon
willlbone Free
02/15/17 9:50 AM
profile icon
LV_Trader Free
01/22/17 10:54 AM
profile icon
ClayTrader Free
01/13/17 5:20 PM
profile icon
TooYoungToDie Free
01/13/17 12:22 PM
profile icon
TooYoungToDie Free
01/13/17 11:52 AM
profile icon
LV_Trader Free
01/12/17 10:00 PM
profile icon
PAC Free
01/12/17 6:58 PM
profile icon
declaes Free
01/12/17 3:37 PM

Opexa Therapeutics, Inc. (OPXA) RSS Feed

Followers
76
Posters
238
Posts (Today)
0
Posts (Total)
1309
Created
03/22/07
Type
Free
Moderators

website - http://www.opexatherapeutics.com/

quote - http://finance.yahoo.com/q/h?s=OPXA

SEC - http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1069308

Opexa Therapeutics, Inc., a development stage biopharmaceutical company, engages in the development and commercialization of autologous cellular therapies for the treatment of multiple sclerosis, rheumatoid arthritis, cardiovascular diseases, and diabetes. These therapies are based on the company's proprietary T-cell and stem cell technologies.

The company's lead product, Tovaxin, is a T-cell-based therapeutic vaccine for multiple sclerosis, which offers an approach to treat the disease by inducing an immune response against the autoimmune myelin-reactive T-cells. Tovaxin is in Phase I/II clinical trials. Opexa Therapeutics also conducts preclinical research to develop stem cell therapies to treat congestive heart failure and Type 1 diabetes, as well as develops rheumatoid arthritis T-cell vaccination technology.  

Tovaxin

- Overview -

by Opexa - http://www.opexatherapeutics.com/tovaxin.php

by BioCentury  -http://www.opexatherapeutics.com/biocentury_10102008.pdf

- Publication Phase I-II_a Trial Results -

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=37280410

- Phase II_b Trial Results -

http://www.opexatherapeutics.com/tovaxintrials.php


- Overview -

http://www.pharmafrontiers.net/media/Monocyte.wmv

- Progress to Date -

http://www.businesswire.com/portal/site/opexa/?ndmViewId=news_view&newsId=20090317005202&newsLang=en

 
Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
OPXA Latest News
  • No Recent News Available for this company!
New Post